Bastiano Sanna's most recent trade in Adicet Bio Inc was a trade of 28,828 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adicet Bio Inc | Bastiano Sanna | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 28,828 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 28,828 | 28,828 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 1,172 | 1,172 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 1,172 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,900 | 5,900 | - | 0 | Common Stock | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 05 May 2023 | 2,850 | 32,038 (0%) | 0% | 350 | 997,500 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 350.03 per share. | 05 May 2023 | 422 | 34,888 (0%) | 0% | 350.0 | 147,713 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 350.44 per share. | 02 May 2023 | 2,053 | 36,038 (0%) | 0% | 350.4 | 719,453 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 350.32 per share. | 02 May 2023 | 1,411 | 38,302 (0%) | 0% | 350.3 | 494,302 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 351.60 per share. | 02 May 2023 | 728 | 35,310 (0%) | 0% | 351.6 | 255,965 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 353.24 per share. | 02 May 2023 | 169 | 38,091 (0%) | 0% | 353.2 | 59,698 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 351.64 per share. | 02 May 2023 | 42 | 38,260 (0%) | 0% | 351.6 | 14,769 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 326.45 per share. | 12 Apr 2023 | 4,068 | 42,338 (0%) | 0% | 326.5 | 1,327,999 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 327.43 per share. | 12 Apr 2023 | 2,625 | 39,713 (0%) | 0% | 327.4 | 859,504 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 325.70 per share. | 12 Apr 2023 | 874 | 46,406 (0%) | 0% | 325.7 | 284,662 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 314.22 per share. | 04 Apr 2023 | 211 | 47,591 (0%) | 0% | 314.2 | 66,300 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 317.65 per share. | 04 Apr 2023 | 96 | 47,311 (0%) | 0% | 317.6 | 30,494 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 315.66 per share. | 04 Apr 2023 | 94 | 47,497 (0%) | 0% | 315.7 | 29,672 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 316.76 per share. | 04 Apr 2023 | 90 | 47,407 (0%) | 0% | 316.8 | 28,508 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 318.68 per share. | 04 Apr 2023 | 31 | 47,280 (0%) | 0% | 318.7 | 9,879 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.74 per share. | 31 Mar 2023 | 1,466 | 47,802 (0%) | 0% | 313.7 | 459,943 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 300.54 per share. | 16 Mar 2023 | 2,482 | 49,532 (0%) | 0% | 300.5 | 745,940 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 301.07 per share. | 16 Mar 2023 | 264 | 49,268 (0%) | 0% | 301.1 | 79,482 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.12 per share. | 24 Feb 2023 | 3,970 | 52,014 (0%) | 0% | 289.1 | 1,147,806 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.85 per share. | 17 Feb 2023 | 3,750 | 55,984 (0%) | 0% | 292.9 | 1,098,188 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 300.29 per share. | 14 Feb 2023 | 1,902 | 60,013 (0%) | 0% | 300.3 | 571,152 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 301.11 per share. | 14 Feb 2023 | 279 | 59,734 (0%) | 0% | 301.1 | 84,010 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.26 per share. | 10 Feb 2023 | 4,340 | 62,028 (0%) | 0% | 298.3 | 1,294,448 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.33 per share. | 10 Feb 2023 | 902 | 66,368 (0%) | 0% | 294.3 | 265,486 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 300.39 per share. | 10 Feb 2023 | 113 | 61,915 (0%) | 0% | 300.4 | 33,944 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 12,314 | 59,404 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 9,092 | 47,090 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 7,866 | 67,270 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 325.00 per share. | 31 Jan 2023 | 106 | 37,998 (0%) | 0% | 325 | 34,450 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.84 per share. | 01 Nov 2022 | 768 | 38,424 (0%) | 0% | 312.8 | 240,261 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 312.40 per share. | 01 Nov 2022 | 100 | 38,229 (0%) | 0% | 312.4 | 31,240 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 313.37 per share. | 01 Nov 2022 | 81 | 38,148 (0%) | 0% | 313.4 | 25,383 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 310.11 per share. | 01 Nov 2022 | 56 | 38,368 (0%) | 0% | 310.1 | 17,366 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 311.18 per share. | 01 Nov 2022 | 39 | 38,329 (0%) | 0% | 311.2 | 12,136 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 317.77 per share. | 01 Nov 2022 | 22 | 38,104 (0%) | 0% | 317.8 | 6,991 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 314.42 per share. | 01 Nov 2022 | 12 | 38,136 (0%) | 0% | 314.4 | 3,773 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 315.70 per share. | 01 Nov 2022 | 10 | 38,126 (0%) | 0% | 315.7 | 3,157 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 300.02 per share. | 18 Oct 2022 | 1,503 | 39,480 (0%) | 0% | 300.0 | 450,930 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 301.84 per share. | 18 Oct 2022 | 288 | 39,192 (0%) | 0% | 301.8 | 86,930 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.62 per share. | 01 Aug 2022 | 766 | 40,983 (0%) | 0% | 276.6 | 211,891 | Common Stock |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 254.00 per share. | 16 May 2022 | 15 | 41,757 (0%) | 0% | 254 | 3,810 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 254.50 per share. | 16 May 2022 | 8 | 41,749 (0%) | 0% | 254.5 | 2,036 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 251.38 per share. | 16 May 2022 | 8 | 41,779 (0%) | 0% | 251.4 | 2,011 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 252.43 per share. | 16 May 2022 | 7 | 41,772 (0%) | 0% | 252.4 | 1,767 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 250.57 per share. | 16 May 2022 | 7 | 41,787 (0%) | 0% | 250.6 | 1,754 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 275.08 per share. | 04 May 2022 | 36 | 41,660 (0%) | 0% | 275.1 | 9,903 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 257.49 per share. | 02 May 2022 | 90 | 41,906 (0%) | 0% | 257.5 | 23,174 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 259.59 per share. | 02 May 2022 | 75 | 41,788 (0%) | 0% | 259.6 | 19,469 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 261.78 per share. | 02 May 2022 | 65 | 41,700 (0%) | 0% | 261.8 | 17,016 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 258.47 per share. | 02 May 2022 | 43 | 41,863 (0%) | 0% | 258.5 | 11,114 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 260.43 per share. | 02 May 2022 | 23 | 41,765 (0%) | 0% | 260.4 | 5,990 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 255.45 per share. | 02 May 2022 | 20 | 41,996 (0%) | 0% | 255.5 | 5,109 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 264.25 per share. | 02 May 2022 | 4 | 41,696 (0%) | 0% | 264.3 | 1,057 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.17 per share. | 29 Apr 2022 | 766 | 42,016 (0%) | 0% | 276.2 | 211,546 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 276.39 per share. | 07 Apr 2022 | 327 | 42,812 (0%) | 0% | 276.4 | 90,380 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 275.71 per share. | 07 Apr 2022 | 204 | 43,139 (0%) | 0% | 275.7 | 56,245 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 277.03 per share. | 07 Apr 2022 | 30 | 42,782 (0%) | 0% | 277.0 | 8,311 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 275.23 per share. | 04 Apr 2022 | 3,163 | 43,343 (0%) | 0% | 275.2 | 870,552 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 267.10 per share. | 04 Apr 2022 | 305 | 46,763 (0%) | 0% | 267.1 | 81,466 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 268.43 per share. | 04 Apr 2022 | 257 | 46,506 (0%) | 0% | 268.4 | 68,987 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.09 per share. | 01 Apr 2022 | 1,344 | 47,068 (0%) | 0% | 263.1 | 353,593 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 250.06 per share. | 17 Mar 2022 | 2,122 | 48,412 (0%) | 0% | 250.1 | 530,627 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.51 per share. | 17 Feb 2022 | 3,439 | 50,534 (0%) | 0% | 232.5 | 799,602 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 237.74 per share. | 10 Feb 2022 | 979 | 53,973 (0%) | 0% | 237.7 | 232,747 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 12,314 | 56,518 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 11,628 | 44,204 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 250.04 per share. | 01 Feb 2022 | 670 | 55,322 (0%) | 0% | 250.0 | 167,527 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.64 per share. | 01 Feb 2022 | 526 | 55,992 (0%) | 0% | 243.6 | 128,155 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 253.07 per share. | 01 Feb 2022 | 149 | 55,032 (0%) | 0% | 253.1 | 37,707 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 251.47 per share. | 01 Feb 2022 | 141 | 55,181 (0%) | 0% | 251.5 | 35,457 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 253.95 per share. | 01 Feb 2022 | 64 | 54,968 (0%) | 0% | 254.0 | 16,253 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 254.56 per share. | 01 Feb 2022 | 16 | 54,952 (0%) | 0% | 254.6 | 4,073 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.07 per share. | 01 Nov 2021 | 766 | 32,576 (0%) | 0% | 185.1 | 141,764 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 200.39 per share. | 30 Jul 2021 | 766 | 33,342 (0%) | 0% | 200.4 | 153,499 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 215.95 per share. | 17 May 2021 | 65 | 34,155 (0%) | 0% | 216.0 | 14,037 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 216.87 per share. | 17 May 2021 | 47 | 34,108 (0%) | 0% | 216.9 | 10,193 | Common Stock |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Bastiano Sanna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 1,172 | 1,172 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 30 Apr 2021 | 766 | 35,068 (0%) | 0% | 217.2 | 166,383 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 218.06 per share. | 30 Apr 2021 | 501 | 34,567 (0%) | 0% | 218.1 | 109,248 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 218.83 per share. | 30 Apr 2021 | 459 | 34,108 (0%) | 0% | 218.8 | 100,443 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 213.89 per share. | 05 Apr 2021 | 1,297 | 36,223 (0%) | 0% | 213.9 | 277,415 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 214.99 per share. | 05 Apr 2021 | 389 | 35,834 (0%) | 0% | 215.0 | 83,631 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.16 per share. | 01 Apr 2021 | 1,344 | 37,520 (0%) | 0% | 214.2 | 287,831 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 210.44 per share. | 11 Feb 2021 | 1,469 | 39,081 (0%) | 0% | 210.4 | 309,136 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Sale of securities on an exchange or to another person at price $ 211.41 per share. | 11 Feb 2021 | 217 | 38,864 (0%) | 0% | 211.4 | 45,876 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.16 per share. | 10 Feb 2021 | 1,344 | 40,550 (0%) | 0% | 214.2 | 287,831 | Common Stock |
| Vertex Pharma | Bastiano Sanna | EVP, Cell & Genetic Therapies | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 11,627 | 41,894 (0%) | 0% | 0 | Common Stock |